EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Using Mass Spectrometry as Quality Control in Medicinal Cannabis
Cannabis plants contain a wide variety of complex compounds including phytocannabinoids terpenoids and flavonoids found mainly in the inflorescences Major phytocannabinoids like CBD and THC have beneficial effects on human health
Designing Early-stage Formulation Strategies for Anti-microbial Peptides (Amps): A Major Prerequisite for Combating Anti-microbial Resistance
At present the world is witnessing an exponential increase in antimicrobial resistance AMR making it important for us to search alternatives to antibiotics in order to combat multidrug resistant MDR bacterial infections According to a study drugresistant infections were responsible for million deaths in globally The number of predicted deaths
Crafting Cures: The Future of Drug Manufacturing
Behind every tablet that eases pain every vial that holds a lifesaving vaccine and every infusion that battles a chronic disease lies a complex and remarkable story It is a story of scientific discovery but more fundamentally
Innovative Pricing Models in the EU: Making Medicines Affordable for All
Pricing policies are important determinants in delivering sufficiently cheap medicines in all the member nations of the EU High costs of meeting the required medical care together with arising independent differentiated technological improvements have rendered exhausted pricing structures as uncompetitive tools for fairness New mechanisms of pricing have been introduced
B2B Pharma Magazines: Sponsored Thought Leadership Strategies for Brand Authority
The pharmaceutical industry has never been short of innovation Every year brings breakthroughs in biologics advanced therapies AIdriven drug discovery manufacturing automation precision medicine and digital health
Precision Oncology Trials: Navigating the Future of Cancer Care
Precision oncology is revolutionizing cancer care offering targeted treatments tailored to each patients unique genetic makeup As we navigate the future of cancer care precision oncology trials are paving the way for more effective and personalized treatment options
-
Techno Trends
Juniper Biosciences Secures FDA Breakthrough Designation
The US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to Juniper Biosciences JBS Ffluoromisonidazole or FMISO for identifying tumour hypoxia in patients with HPVpositive oropharyngeal carcinoma OPC
-
Projects
Onyx Scientific to Invest Over US$2 Million (£1.5 Million) in Sunderland GMP Facility Expansion
Onyx Scientific is investing more than US Million Million to expand its Good Manufacturing Practice GMP facilities at its Sunderland UK site The investment will increase capacity for commercial
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Designing Early-stage Formulation Strategies for Anti-microbial Peptides (Amps): A Major Prerequisite for Combating Anti-microbial Resistance
Sintu Kumar Samanta
Ananya Anurag Anand
Biological formulation of drugs is critical to ensure their effective delivery within the patient’s body. It involves the determination of appropriate substances that can be combined with active...
-
2
Crafting Cures: The Future of Drug Manufacturing
Dr. Amrish Chandra
Drug manufacturing transforms scientific discoveries into safe, effective therapies. Emerging technologies such as continuous manufacturing, artificial intelligence, real-time monitoring, and digital...
-
3
Innovative Pricing Models in the EU: Making Medicines Affordable for All
Debi Jones
In this article, we discuss new approaches to drug pricing in the EU: value based pricing, risk sharing, subscription and differential pricing. These strategies are to achieve cost reduction for medic...
-
4
B2B Pharma Magazines: Sponsored Thought Leadership Strategies for Brand Authority
Kate Williamson
Decision-makers in the pharmaceutical industry rarely respond to promotional messaging alone. They look for evidence, expertise, and credible perspectives that help solve complex business and scientif...
-
5
Precision Oncology Trials: Navigating the Future of Cancer Care
Kate Williamson
Precision oncology trials are transforming cancer care by targeting genetic mutations for personalized treatments. This article discusses trial types, challenges like genomic profiling, key components...
press releases Read more...
Amneal Announces FDA Approval and Launch of Lanreotide Injection
Amneal Pharmaceuticals Inc Amneal or the Company NASDAQ AMRX today announced that the US Food and Drug Administration FDA has approved its lanreotide injection mg mL in a sterile
Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer
Nuvation Bio Inc NYSE NUVB a global oncology company focused on tackling some of the toughest challenges in cancer treatment today announced that the US Food and Drug Administration FDA
Acelot Announces Initiation of Dosing in Phase Ia Clinical Trial of ACE-2223, a First-in-Class Oral Small Molecule Targeting Aggregated TDP-43 in Amyotrophic Lateral Sclerosis (ALS)
Acelot a biotechnology company developing small molecule therapies for challenging targets in diseases with high unmet need today announced the initiation of the Phase Ia clinical trial of ACE
Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution
Mission Bio a leader in singlecell multiomics today announced Tapestri Triomics a new expansion of the Tapestri Platform that simultaneously analyzes DNA RNA and protein in the same cell By connecting genotype
Events Read more...
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
LATEST NEWS Read more...
BioCytics and Eremid collaborate on single-cell sequencing study for cancer cell therapy
BioCytics Inc has engaged Eremid Genomic Services to sequence an autologous immune cell fraction being developed for its immunebased cancer cell therapy programme
MAbxience and Sandoz collaborate to advance global access to emicizumab biosimilar
MAbxience majorityowned by Fresenius SE Co KGaA with partial ownership from Insud Pharma has entered into a licensing development manufacturing and commercialisation agreement with Sandoz for an emicizumab
Orbis Medicines enters multi-target drug discovery partnership with Novo Nordisk
Orbis Medicines has entered a strategic collaboration and licence agreement with Novo Nordisk to discover and develop nextgeneration oral macrocycle medicines for cardiometabolic diseases
Everest Clinical Research expands global biometrics capabilities with Firma DS acquisition
Everest Clinical Research has acquired the Biometrics and Data Services business unit of Firma Clinical Research expanding its global biometrics expertise and clinical data science capabilities
Novo Nordisk and Anthropic collaborate to advance AI-led drug discovery
Novo Nordisk and Anthropic have announced a collaboration to accelerate drug discovery and development using artificial intelligence AI while also expanding AIsupported software development at Novo
Twist Bioscience joins Lilly TuneLab to support antibody drug discover
Twist Bioscience has entered into an agreement with Lilly TuneLab an artificial intelligence and machine learning AIML drug discovery platform developed by Eli Lilly and Company





